Page 8 - Pharma Stocks

Green shoots seen in June pharma sales as domestic market grows 2.4%

The turn around follows deep decline in sales in the preceding months; July sales likely to be flat

This pharma stock zooms over 100% in 18 trading days

The stock hit a new high of Rs 723 during the day, up 16 per cent.

Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%

At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index

Mid, small-cap pharma stocks rally; Dishman Carbogen, Unichem Labs soar 20%

Panacea Biotec, Nectar Lifesciences, and Vimta Labs, too, were frozen at 20 per cent upper circuit on the BSE.

Strong Q4 performance, debt reduction show Aurobindo Pharma in good health

Despite an over 150 per cent rise since March lows, the stock can see more gains

Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018

Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.

Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%

At present there are three clinical trials underway to test nafamostat in Covid19 patients around the world

Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high

Dr Reddy's, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.

Sun Pharma's Q4 pre-tax profit down 17% at Rs 577 cr on multiple one-offs

Revenues in the US market, its largest geography, came in at $375 million down 15 per cent, though the year ago period had a high base due to a one-time contribution of specialty products

Price drives growth of Rs 1.4 trillion pharma market, hits a five-year high

The rapid growth of the trade generics market which accounts for a third of pharma volumes is another trend which is impacting volume as well as overall growth of the branded segment

Pharma index set to post its biggest monthly gain in 21 years amid Covid-19

Analysts, however, do caution against the rich valuation the pharma index and the stocks are trading at

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Cipla, Biocon, Divi's Lab: Pharma stocks to bet on in the current market

Cipla may see profit-booking around Rs 360 to Rs 367 levels, as per the weekly chart.

Growth in domestic market likely to provide booster dose for pharma stocks

The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row

Pharma stocks advance; Ipca Labs, Cadila Healthcare soar up to 19%

Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say.

Market Wrap, Feb 25: Sensex slips 82 pts, Nifty gives up 11,800

On the sectoral front, Nifty Pharma index dropped over 2 per cent to end as the biggest sectoral index loser. The index closed at 7,937 levels

FIIs rejig sectoral exposure ahead of Budget; pick pharma stocks, drop IT

Investors bet in anticipation of easing of regulatory issues in the pharma segment

Pharma stocks gain; Divi's Labs, Dr Reddy's, Pirmal Enterprises rise 1.50%

Indian pharma market (IPM) registered a 14.5 per cent year-on-year (YoY) growth in November, one of the best growths seen in more than 32 months.

Dr Reddy's Labs shines among pharma stocks, wins investor confidence

The Hyderabad-based company is an outlier among large pharmaceutical producers, having seen a jump in its stock price over the previous year

From Dr Reddy's to Cipla, pharma companies aren't out of the woods: Experts

The Street is cautious given multiple challenges in core markets of US and India